Drug Export; Atenolol Bulk Drug Substance

الملخص

The Food and Drug Administration (FDA) is announcing that IPR Pharmaceuticals, Inc., a part of Zeneca Group PLC, has filed an application requesting approval for the export of the bulk drug substance Atenolol to France to produce various approved finished formulations containing Atenolol alone or in combination.